1. Home
  2. FOLD vs LAZ Comparison

FOLD vs LAZ Comparison

Compare FOLD & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.49

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Logo Lazard Inc.

LAZ

Lazard Inc.

HOLD

Current Price

$41.82

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
LAZ
Founded
2002
1848
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.7B
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
FOLD
LAZ
Price
$14.49
$41.82
Analyst Decision
Buy
Hold
Analyst Count
9
8
Target Price
$27.25
$52.75
AVG Volume (30 Days)
2.5M
1.1M
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
4.21%
EPS Growth
50.00
N/A
EPS
N/A
0.91
Revenue
N/A
$3,186,466,000.00
Revenue This Year
$20.50
$13.36
Revenue Next Year
$18.59
$13.72
P/E Ratio
N/A
$51.98
Revenue Growth
N/A
1.48
52 Week Low
$5.66
$38.67
52 Week High
$14.50
$58.75

Technical Indicators

Market Signals
Indicator
FOLD
LAZ
Relative Strength Index (RSI) 74.18 36.63
Support Level $14.21 $38.84
Resistance Level N/A $51.31
Average True Range (ATR) 0.02 2.37
MACD -0.00 -0.50
Stochastic Oscillator 100.00 1.87

Price Performance

Historical Comparison
FOLD
LAZ

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About LAZ Lazard Inc.

Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.

Share on Social Networks: